Keep me logged in
Forgot your password?

Sentinel Node

News

Events

Recent Articles


1. Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA.
ABOUT TOPICS

2. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance.
ABOUT TOPICS

3. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
ABOUT TOPICS

4. Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.
ABOUT TOPICS

5. Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus.
ABOUT TOPICS

6. Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
ABOUT TOPICS

7. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ.
ABOUT TOPICS

8. Outlining the body contours with scattered photons in lymphoscintigraphy for sentinel nodes.
ABOUT TOPICS

9. Fusion lymphoscintigraphy with a 24-hour Tc-99m MDP bone scan for sentinel lymph node detection and imaging.
ABOUT TOPICS

10. Is the upright position more sensitive than the supine position in breast cancer sentinel node lymphoscintigraphy?
ABOUT TOPICS

11. The role of dynamic imaging in sentinel lymph node biopsy in breast cancer.
ABOUT TOPICS

12. Improved body-outline imaging technique for localization of sentinel lymph nodes in breast surgery.
ABOUT TOPICS

13. Enhanced sentinel lymphoscintigraphic mapping in breast tumor using the graded shield technique.
ABOUT TOPICS

14. Sentinel node scintigraphy in breast cancer using a dual tracer technique.
ABOUT TOPICS

15. Lymphoscintigraphy for the visualization of sentinel lymph nodes and body contour.
ABOUT TOPICS

16. Reducing exposure from 57Co sources during breast lymphoscintigraphy by optimizing energy windows and other suggested enhancements of acquisition and the display of images.
ABOUT TOPICS

17. Improved detection of axillary hot nodes in lymphoscintigraphy in breast cancer located in the upper lateral quadrant with additional projection imaging.
ABOUT TOPICS

18. Localization of sentinel nodes in breast cancer: novel method and device to help pen marking of active nodes during gamma camera imaging.
ABOUT TOPICS

19. The influence of wire localisation for non-palpable breast lesions on visualisation of the sentinel node.
ABOUT TOPICS

20. Stereoscopic scintigraphic imaging of breast cancer sentinel lymph nodes.
ABOUT TOPICS

21. Advantages of upright position imaging with medium-energy collimator for sentinel node lymphoscintigraphy in breast cancer patients.
ABOUT TOPICS

22. Radioguided localisation (ROLL) of non-palpable breast lesions and simultaneous sentinel lymph node biopsy (SNOLL): the experience of the European Institute of Oncology.
ABOUT TOPICS

23. Lymphoscintigraphic and intraoperative detection of sentinel lymph nodes.
ABOUT TOPICS

24. The value of imaging in standing position in preoperative breast lymphoscintigraphy.
ABOUT TOPICS

25. Towards intra-operative 3D nuclear imaging: reconstruction of 3D radioactive distributions using tracked gamma probes.
ABOUT TOPICS

26. Optimization of Coded Aperture Radioscintigraphy for Sentinel Lymph Node Mapping.
ABOUT TOPICS

27. Sentinel node detection in patients with breast cancer: low-energy all-purpose collimator or medium-energy collimator?
ABOUT TOPICS

28. Assessment of the solid-state gamma camera to depict axillary sentinel lymph nodes in breast cancer patients.
ABOUT TOPICS

29. Development of a GSO positron/single-photon imaging detector.
ABOUT TOPICS

30. Usefulness of medium-energy collimator for sentinel node lymphoscintigraphy imaging in breast cancer patients.
ABOUT TOPICS

31. Detection of sentinel node in breast cancer: pilot study with the imaging probe.
ABOUT TOPICS

32. Intraoperative sentinel node detection by an innovative imaging probe.
ABOUT TOPICS

33. A hand-held imaging probe for radio-guided surgery: physical performance and preliminary clinical experience.
ABOUT TOPICS

34. A prototype small CdTe gamma camera for radioguided surgery and other imaging applications.
ABOUT TOPICS

35. Usefulness of a solid-state gamma camera for sentinel node identification in patients with breast cancer.
ABOUT TOPICS

36. Precise localization of sentinel lymph nodes and estimation of their depth using a prototype intraoperative mini gamma-camera in patients with breast cancer.
ABOUT TOPICS

37. Place of a hand-held gamma camera (POCI) in the breast cancer sentinel node biopsy.
ABOUT TOPICS

38. Intraoperative gamma imaging of axillary sentinel lymph nodes in breast cancer patients.
ABOUT TOPICS

39. Image processing algorithms to facilitate and enhance sentinel node detection using a hand-held gamma ray camera in surgical breast cancer staging.
ABOUT TOPICS

40. A GSO positron/single-photon imaging detector.
ABOUT TOPICS

41. Optimization of sentinel lymph node biopsy in breast cancer using an operative gamma camera.
ABOUT TOPICS

42. High-resolution, hand-held camera for sentinel-node detection.
ABOUT TOPICS

43. A new intraoperative gamma camera for the sentinel lymph node procedure in breast cancer.
ABOUT TOPICS

44. Added Value of Intraoperative Real-Time Imaging in Searches for Difficult-to-Locate Sentinel Nodes.
ABOUT TOPICS

45. The use of a portable gamma camera for preoperative lymphatic mapping: a comparison with a conventional gamma camera.
ABOUT TOPICS

46. Evaluation of a CdTe semiconductor based compact gamma camera for sentinel lymph node imaging.
ABOUT TOPICS

47. A computerized gamma probe simulator to train surgeons in the localization of sentinel nodes.
ABOUT TOPICS

48. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma.
ABOUT TOPICS

49. Controlled introduction of the sentinel node biopsy in breast cancer in a multi-centre setting: the role of a coordinator for quality control.
ABOUT TOPICS

50. Credentialing issues with sentinel lymph node staging for breast cancer.
ABOUT TOPICS

51. Localizing the sentinel node outside of the specialty center: success of a lymphatic mapping course in disseminating new technology.
ABOUT TOPICS

52. Review of sentinel lymph node credentialing: how many cases are enough?
ABOUT TOPICS

53. The learning curve and sentinel node biopsy.
ABOUT TOPICS

54. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis.
ABOUT TOPICS

55. An evaluation of resident training in breast procedures.
ABOUT TOPICS

56. How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer?
ABOUT TOPICS

57. A model for teaching sentinel lymph node mapping and excision and axillary lymph node dissection.
ABOUT TOPICS

58. Development and evaluation of sentinel node biopsy: a continuing professional development course.
ABOUT TOPICS

59. Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative bre
ABOUT TOPICS

60. A training simulator for sentinel node biopsy in breast cancer: a new standard.
ABOUT TOPICS

61. Implementation of sentinel lymph node biopsy with blue dye outside a specialized center: can we improve quality assurance?
ABOUT TOPICS

62. Sweet nuclear medicine phantoms for scintigraphic sentinel lymph node detection: a cooking recipe.
ABOUT TOPICS

63. Prevalence of teaching sentinel lymph node biopsy for breast cancer in general surgery residency programs.
ABOUT TOPICS

64. Effects of sentinel lymph node biopsy on surgical residency training.
ABOUT TOPICS

65. Improvement in sentinel node biopsy results in a teaching community hospital: results of a multidisciplinary quality improvement program.
ABOUT TOPICS

66. Surgeon Training, Protocol Compliance, and Technical Outcomes From Breast Cancer Sentinel Lymph Node Randomized Trial.
ABOUT TOPICS

67. Beyond the False Negative Rate: Development of Quality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer.
ABOUT TOPICS

68. The Komen Foundation: ACS Outreach Collaboration-Sentinel Lymph Node Biopsy Training for Practicing Surgeons in Remote or Underserved Communities.
ABOUT TOPICS

69. Implementing Sentinel Lymph Node Biopsy Programs in Developing Countries: Challenges and Opportunities.
ABOUT TOPICS

70. Enhancing the quality of care for patients with breast cancer: Seven years of experience with a Dutch auditing system.
ABOUT TOPICS

71. Preparation of 99mTc-Nanocoll for use in sentinel node localization: Validation of a protocol for supplying in unit-dose syringes.
ABOUT TOPICS

72. (99m)Tc Nanocoll: A radiopharmaceutical for sentinel node localisation in breast cancer-In vitro and in vivo results.
ABOUT TOPICS

73. Particle size of tin and phytate colloid in sentinel node identification.
ABOUT TOPICS

74. Particle sizes of colloids to be used in sentinel lymph node radiolocalization.
ABOUT TOPICS

75. Sentinel Node Mapping with Thermoresponsive Magnetic Nanoparticles in Rats.
ABOUT TOPICS

76. 99mTc-labeled mannosyl-neoglycoalbumin for sentinel lymph node identification.
ABOUT TOPICS

77. Kit for preparation of multimeric receptor-specific 99mTc-radiopharmaceuticals based on gold nanoparticles.
ABOUT TOPICS

78. Combining dose and injection volume for good performance of a specific radiopharmaceutical for sentinel node detection.
ABOUT TOPICS

79. (99m)Tc-labelled gold nanoparticles capped with HYNIC-peptide/mannose for sentinel lymph node detection.
ABOUT TOPICS

80. Sentinel node biopsy and lymphoscintigraphy with a technetium 99m labeled blue dye in a rabbit model.
ABOUT TOPICS

81. Why certain dyes are useful for localizing the sentinel lymph node.
ABOUT TOPICS

82. A new agent, blue and radioactive, for sentinel node detection.
ABOUT TOPICS

83. Development of 125I-methylene blue for sentinel lymph node biopsy.
ABOUT TOPICS

84. Large-Scale Synthesis of Bioinert Tantalum Oxide Nanoparticles for X-ray Computed Tomography Imaging and Bimodal Image-Guided Sentinel Lymph Node Mapping.
ABOUT TOPICS

85. Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer-implications for use in pregnancy.
ABOUT TOPICS

86. Aggregation-enhanced fluorescence in PEGylated phospholipid nanomicelles for in vivo imaging.
ABOUT TOPICS

87. Trafficking of a Dual-Modality Magnetic Resonance and Fluorescence Imaging Superparamagnetic Iron Oxide-Based Nanoprobe to Lymph Nodes.
ABOUT TOPICS

88. Targeted non-covalent self-assembled nanoparticles based on human serum albumin.
ABOUT TOPICS

89. Sentinel lymph node uptake of two different technetium-labeled radiocolloids,.
ABOUT TOPICS

90. Sentinel node imaging via a nonparticulate receptor-binding radiotracer.
ABOUT TOPICS

91. Filtered versus unfiltered technetium sulfur colloid in lymphatic mapping: a significant variable in a pig model.
ABOUT TOPICS

92. Active macromolecule uptake by lymph node antigen-presenting cells: a novel mechanism in determining sentinel lymph node status.
ABOUT TOPICS

93. Comparison of intradermal and subcutaneous injections in lymphatic mapping.
ABOUT TOPICS

94. In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification.
ABOUT TOPICS

95. Evaluation of [(99m)Tc] liposomes as lymphoscintigraphic agents: comparison with [(99m)Tc] sulfur colloid and [(99m)Tc] human serum albumin.
ABOUT TOPICS

96. Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran .
ABOUT TOPICS

97. Optimal particle size of radiocolloid for sentinel node identification in breast cancer-electron microscopic study and clinical comparison.
ABOUT TOPICS

98. Phytate technetium-99m versus dextran 500 technetium-99m in the sentinel lymph node biopsy.
ABOUT TOPICS

99. Immunolymphoscintigraphy for metastatic sentinel nodes: test of a model.
ABOUT TOPICS

100. Dual-isotope lymphoscintigraphy using albumin nanocolloid differentially labeled with 111In and 99mTc.
ABOUT TOPICS

101. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study.
ABOUT TOPICS

102. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer.
ABOUT TOPICS

103. Indocyanine green fluorescence imaging system for sentinel lymph node biopsies in early breast cancer patients.
ABOUT TOPICS

104. Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients.
ABOUT TOPICS

105. Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer.
ABOUT TOPICS

106. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
ABOUT TOPICS

107. In Vivo Imaging of Sentinel Nodes Using Fluorescent Silica Nanoparticles in Living Mice.
ABOUT TOPICS

108. Measurement of lymph node function from the extraction of immunoglobulin in lymph.
ABOUT TOPICS

109. Quantitative Imaging of Lymphatic Function with Liposomal Indocyanine Green.
ABOUT TOPICS

110. Development of (68)Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography.
ABOUT TOPICS

111. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.
ABOUT TOPICS

112. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
ABOUT TOPICS

113. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
ABOUT TOPICS

114. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes.
ABOUT TOPICS

115. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR.
ABOUT TOPICS

116. RT-PCR detection of breast cancer cells in sentinel lymph modes.
ABOUT TOPICS

117. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes.
ABOUT TOPICS

118. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.
ABOUT TOPICS

119. Immunohistochemistry and reverse transcriptase polymerase chain reaction on sentinel lymph nodes can improve the accuracy of nodal staging in breast cancer patients.
ABOUT TOPICS

120. Detection of micrometastasis in the sentinel lymph nodes in breast cancer.
ABOUT TOPICS

121. Detection of micrometastases in lymph nodes from patients with breast cancer.
ABOUT TOPICS

122. Molecular lymphatic mapping of the sentinel lymph node.
ABOUT TOPICS

123. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer.
ABOUT TOPICS

124. Quantitative evaluation of metastases in axillary lymph nodes of breast cancer.
ABOUT TOPICS

125. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers.
ABOUT TOPICS

126. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
ABOUT TOPICS

127. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.
ABOUT TOPICS

128. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study.
ABOUT TOPICS

129. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
ABOUT TOPICS

130. An evaluation of molecular markers for improved detection of breast cancer metastases in sentinel nodes.
ABOUT TOPICS

131. Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA.
ABOUT TOPICS

132. Molecular markers of breast cancer cells identified in fine needle aspiration samples from resected sentinel lymph nodes.
ABOUT TOPICS

133. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
ABOUT TOPICS

134. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
ABOUT TOPICS

135. Technical limits of comparison of step-sectioning, immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn fixed tissue.
ABOUT TOPICS

136. Patterns of DNA copy number changes in sentinel lymph node breast cancer metastases.
ABOUT TOPICS

137. Pathological examination with two-millimetre serial sectioning for sentinel lymph node biopsies in breast cancer.
ABOUT TOPICS

138. FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients.
ABOUT TOPICS

139. Utility of the GeneSearch breast lymph node assay for the rapid evaluation of sentinel lymph nodes in breast cancer.
ABOUT TOPICS

140. Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
ABOUT TOPICS

141. Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels.
ABOUT TOPICS

142. Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA).
ABOUT TOPICS

143. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy.
ABOUT TOPICS

144. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence.
ABOUT TOPICS

145. Altered lymphatic drainage after breast-conserving surgery and axillary node dissection: local recurrence with contralateral intramammary nodal metastases.
ABOUT TOPICS

146. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence.
ABOUT TOPICS

147. Sentinel lymph node biopsy in operations for recurrent breast cancer.
ABOUT TOPICS

148. Reoperative sentinel lymph node biopsy after previous mastectomy.
ABOUT TOPICS

149. Sentinel Lymph Node Biopsy in Patients with Previous Ipsilateral Complete Axillary Lymph Node Dissection.
ABOUT TOPICS

150. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer.
ABOUT TOPICS

151. Lymphatic mapping and sentinel node biopsy in women with an ipsilateral second breast carcinoma and a history of breast and axillary surgery.
ABOUT TOPICS

152. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer.
ABOUT TOPICS

153. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
ABOUT TOPICS

154. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy.
ABOUT TOPICS

155. Sentinel lymph node surgery in locally recurrent breast cancer.
ABOUT TOPICS

156. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer.
ABOUT TOPICS

157. Sentinel lymph node biopsy is feasible even after total mastectomy.
ABOUT TOPICS

158. Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer.
ABOUT TOPICS

159. Role of re-operative sentinel lymph node biopsy in locally recurrent breast cancer.
ABOUT TOPICS

160. Reoperative sentinel lymph node biopsy in ipsilateral breast cancer relapse.
ABOUT TOPICS

161. Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure.
ABOUT TOPICS

162. Axillary sentinel lymph node biopsy after mastectomy: a case report.
ABOUT TOPICS

163. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.
ABOUT TOPICS

164. Keratin immunohistochemistry does not contribute to correct lymph node staging in patients with invasive lobular carcinoma.
ABOUT TOPICS

165. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.
ABOUT TOPICS

166. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.
ABOUT TOPICS

167. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer.
ABOUT TOPICS

168. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center.
ABOUT TOPICS

169. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.
ABOUT TOPICS

170. Clinical and histological factors associated with sentinel node identification in breast cancer.
ABOUT TOPICS